AIHTA - Publications - Search - Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019

Reinsperger, I. and Geiger-Gritsch, S. (2019): Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019. Decision Support Document 100/ Update 2019.

[thumbnail of DSD_100_Update2019.pdf]
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Obstructive sleep apnea is a sleep-related breathing disorder that is caused by a collapse of the upper airway. Current standard therapy is the continuous positive airway pressure therapy (CPAP), which is limited in its effectiveness due to poor compliance. A new functional therapy approach is the stimulation of the hypoglossal nerve (HNS) by an implantable device to restore the tone of the upper airway dilator muscles.

The update search for this first update did not identify any additional RCTs for assessing effectiveness. For safety assessment, we included five single-arm prospective studies and one registry study.

The inclusion in the Austrian catalogue of benefits is currently not recommended based on the available evidence. A new evaluation is proposed for the year 2021.

Item Type:Decision Support Document
Keywords:Obstructive sleep apnea, hypoglossal nerve, electric stimulation
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
W Health professions > W 100-275 Medical, dental and pharmaceutical service plans
WL Nervous system > WL 200-405 Central nervous system. Disorders. Therapeutics
WF Respiratory system
WO Surgery > WO 505 Minimally invasive surgical procedures
Series Name:Decision Support Document 100/ Update 2019
Deposited on:15 Jul 2019 06:40
Last Modified:15 Jul 2020 17:59

Repository Staff Only: item control page